Edition:
United Kingdom

Cipla Ltd (CIPL.NS)

CIPL.NS on National Stock Exchange of India

509.40INR
18 Jan 2019
Change (% chg)

Rs-0.20 (-0.04%)
Prev Close
Rs509.60
Open
Rs510.20
Day's High
Rs513.00
Day's Low
Rs507.30
Volume
1,502,360
Avg. Vol
2,421,932
52-wk High
Rs678.45
52-wk Low
Rs503.00

Chart for

About

Cipla Limited is a holding company. The Company is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered... (more)

Overall

Beta: 0.47
Market Cap(Mil.): Rs471,067.19
Shares Outstanding(Mil.): 804.69
Dividend: 2.00
Yield (%): 0.34

Financials

  CIPL.NS Industry Sector
P/E (TTM): 43.76 30.48 33.71
EPS (TTM): 13.38 -- --
ROI: -- 14.98 14.48
ROE: -- 16.31 15.99

UPDATE 1-India's Cipla warns of headwinds in second half after Q2 profit miss

Nov 5 Cipla Ltd, India's second-largest drugmaker by market capitalisation, warned on Monday of "multiple headwinds" in the second half of the financial year after its quarterly profit fell short of analysts' estimates.

05 Nov 2018

India's Cipla Q2 profit dips nearly 11 pct, misses estimate

Nov 5 Drugmaker Cipla Ltd posted a nearly 11 percent fall in second-quarter profit on Monday, much lower than analyst expectations.

05 Nov 2018

UPDATE 1-India's Sun Pharma Q1 profit beats estimates as U.S. sales climb

* Stock top gainer on NSE index (Adds details on U.S. and India sales, share movement)

14 Aug 2018

UPDATE 1-India's Cipla Q1 profit trumps estimates on strong domestic growth

* India revenue up 22 pct (Adds detail, share movement, appointment of global COO)

08 Aug 2018

India's Cipla Q1 profit trumps estimates

Aug 8 Cipla Ltd, India's third-largest drugmaker by market capitalisation, posted on Wednesday a more than 10 percent rise in its first-quarter profit, well above analysts' expectations.

08 Aug 2018

Earnings vs. Estimates